The Role of the NIH Clinical Center in Translational and Clinical Research
|
|
- Bethany Glenn
- 5 years ago
- Views:
Transcription
1 The Role of the NIH Clinical Center in Translational and Clinical Research International Conference on Engineering Science and Technology 2014 John I. Gallin, M.D. Director, NIH Clinical Center Associate Director for Clinical Research June 2, 2014
2 Outline NIH Overview and Current Areas of Emphasis in Clinical Research New Activities at the NIH Clinical Center
3 The National Institutes of Health The Nation s Steward of Medical & Behavioral Research Science in pursuit of fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to extend healthy life and reduce illness and disability.
4 The National Institutes of Health NCI NINR NCCAM NHLBI OD NIAMS NIEHS NIMHD NIDA NLM NIMH NEI NHGRI NIBIB NCATS NINDS NIDCR NIDDK NIGMS FIC NIA NIAAA NIAID NICHD NIDCD CSR CC CIT Extramural only No Funding Authority
5 NIH Extramural & Intramural Funding FY 2014: $30.15 Billion Spending at NIH Spending Outside NIH
6 NIH s Commitment to Basic Research Applied Research Basic Research
7 NIH s Impact on U.S. Health and Medicine 80 U.S. Life Expectancy Life expectancy gains worth ~$3.2 trillion annually NIH Accomplishments Reduction Cardiovascular in deaths disease from: Heart death disease rates have fallen > 60% Stroke in the last half-century HIV HIV/AIDS therapies enable people in their 20s to live to age 70+ Increased survival rates for: Cancer Breast cancer rates now falling ~1% Cervical per year; cancer each 1% drop Colon saves cancer ~$500 billion
8 Biomedical Research Stimulates the Economy In 2011 NIH funding generated $62 billion in new U.S. economic activity double the taxpayers investment
9 NIH Leading the Way Genomics Cellular Therapy/Regenerative Medicine Vaccine Development Human Microbiome BRAIN initiative Big Data Problem
10 S-01 J-02 M-02 S-02 J-03 M-03 S-03 J-04 M-04 S-04 J-05 M-05 S-05 J-06 M-06 S-06 J-07 M-07 S-07 J-08 M-08 S-08 J-09 M-09 S-09 J-10 M-10 S-10 J-11 M-11 S-11 J-12 M-12 S-12 J-13 M-13 S-13 J-14 Cost of Sequencing a Human Genome September 2001 January 2014 $100,000,000 $10,000,000 $1,000,000 $100,000 $10,000 4,008 $1,000
11 Disorders with Known Molecular Basis ~500 with therapy Source: Online Mendelian Inheritance in Man, Morbid Anatomy of the Human Genome
12 The Cancer Genome Atlas: Comparing Fingerprints of Cancer Types Coordinated effort to accelerate understanding of cancer through genome analysis to improve ability to diagnose, treat, and prevent cancer Searching for shared genomic fingerprints 12 cancer types Tumor samples from 3,300 patients Found 127 significantly mutated genes shared by subsets of samples across cancer types Potential significance for Therapeutic development identifying key cellular pathways to find likely drug targets Precision medicine customizing treatment for individual patients
13 Developing Promise of Cellular Therapy ipscs To study toxicology Generate tissues and cells for transplantation Understand how to prevent and treat birth defects Cellular therapy
14 Vaccine Development The Need for a Universal Flu Vaccine Up to 50,000 U.S. deaths associated with flu annually $87 billion in economic costs Protection currently involves getting a flu shot every year Universal vaccine: one shot provides lasting immunity to most strains Vaccine would also protect against an emerging flu pandemic
15 The Human Microbiome: Transforming Our Understanding of Health and Disease Herbivores Omnivores Carnivores
16 The Brain Initiative The Next Great American Project Learning the Language of the Brain (NIH initial investment $40M)
17 BRAIN Initiative NIH goals Generate a Census of Cell Types Create Structural Maps of the Brain Develop New Large-Scale Network Recording Capabilities Develop A Suite of Tools for Circuit Manipulation Link Neuronal Activity to Behavior Integrate Theory, Modeling, Statistics, and Computation with Experimentation Assure ethical issues considered
18 The Big Data Problem
19 Exposure Clinical Myriad Data Types Genomic Other Omic Imaging Phenotypic
20 NIH Is Tackling the Big Data Problem Big Data to Knowledge (BD2K) Major trans-nih initiative Goal: by decade's end, enable a quantum leap in the ability of the biomedical research enterprise to maximize the value of the growing volume and complexity of biomedical data
21 Despite advances and promise, translational research has problems Slow Expensive NIH National Center for Advancing Translational Sciences
22 NIH Clinical Center World s largest clinical research center Founded 1953 There s no other hospital like it
23 Clinical Center Profile >480,000 patients since opening in beds; 2014 Budget $402.8M Hospital surrounded by research labs Every patient is on a research protocol Care is free Patient travel/housing provided as needed ~6,500 employees 1,255 credentialed physicians 1,530 active protocols Interventional/Clinical Trials (47%) Natural History (47%) Screening - 66 (4%) Training - 26 (2%)
24 Major Emphasis Study of the pathophysiology of disease First in human with new therapeutics Study of patients with rare diseases million people in the United States have a rare disease!
25 Rare Diseases: Window on Nature? Nature is nowhere accustomed more openly to display her secret mysteries than in cases where she shows traces of her workings apart from the beaten path; nor is there any better way to advance the proper practice of medicine than to give our minds to the discovery of the usual law of nature, by the careful investigation of cases of rarer forms of disease. ~ William Harvey, Letter IX, to John Vlackveld, 24 Apr 1657
26 Studies at CC of Rare Diseases with Impact X-SCIDS on a Common Disease Disease Model for Drug Choriocarcinoma Cancer Farnesyltransferase Chemotherapy Progeria Tangier Lamin A in Aging Cardiovascular Disease ( HDL) Immunoregulation (Janus Kinases) Inhibitors (under development) Statins Tofacitinib for RA, Psoriasis, Ulcer.colitis Photo: The Progeria Research Foundation Source: NIH Director s Blog
27 Clinical Center-The Future Disease prevention Linkage of genotype and phenotype to develop new therapeutics for preventing and treating disease Cellular therapy Imaging For immunotherapy of certain cancers and for organ replacement Detection of finer and finer perturbations of structure and function to diagnose and stage disease Information technology Develop portals to merge diverse data sets to guide research and future patient care Training tomorrow s translational and clinical investigators
28 New NIH Grants Opportunities for Collaborative Research at the NIH Clinical Center Supports collaborative research to enhance the translation of basic biological discoveries into clinical applications that improve health Up to $500K/year in direct costs x 3 years, renewable Teams must have 1 outside and 1 intramural co-principal investigator; international partners welcome Some work must be done at the Clinical Center resources/
29 Concluding Messages Solving health issues is a global challenge requiring international cooperation. The NIH Clinical Center is a special resource and by opening its doors to investigators in the United States and internationally we hope to continue to catalyze future research.
30 Thank you!
NIH Institutes and Areas of SBIR Research: (shown in order of FY 2010 Funding amounts)
NIH Institutes and Areas of SBIR Research: (shown in order of FY 2010 Funding amounts) 1. NCI (National Cancer Institute) cancer cause, prevention, detection, diagnosis, treatment and control 2. NIAID
More informationDisruptive Innovation at the NIH. Kathy Hudson, Ph.D. Deputy Director Science, Outreach, and Policy National Institutes of Health
Disruptive Innovation at the NIH Kathy Hudson, Ph.D. Deputy Director Science, Outreach, and Policy National Institutes of Health NIH: Steward of Medical and Behavioral Research for the Nation Science in
More informationNational Institutes of Health 101
National Institutes of Health 101 Perry Kirkham, Ph.D. Office of the Executive Vice President for Research and Partnerships E-mail: pkirkham@purdue.edu Phone: 63645 Questions and topics to be addressed
More informationChristopher P. Austin, M.D. Director, NCATS IOM CTSA Review Committee January 24, 2013
Christopher P. Austin, M.D. Director, NCATS IOM CTSA Review Committee January 24, 2013 Basic Laboratory Research Clinical Research Improved Public Health Translational Research Population Research Basic
More informationAnalyzing and utilizing NIH award data Perry Kirkham, Ph.D.
Analyzing and utilizing NIH award data Perry Kirkham, Ph.D. Office of the Vice President for Research E-mail: pkirkham@purdue.edu Phone: 63645 What decisions can be informed through the use of NIH data?
More informationLili M. Portilla, MPA Acting Director, Office of Policy, Communications and Strategic Alliances National Center for Advancing Translational Sciences
Lili M. Portilla, MPA Acting Director, Office of Policy, Communications and Strategic Alliances National Center for Advancing Translational Sciences (NCATS), NIH GUIRR Meeting, October 9, 2012 Established
More informationOrgans on Chips: The Future of Translational Research
Organs on Chips: The Future of Translational Research KRISTIN FABRE, PHD SCIENTIFIC PROGRAM MANAGER NIH NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCE (NCATS) 1 Advancing regulatory sciences Drug
More informationBIOMATERIALS, BIOMECHANICS AND STEM CELLS
BIOMATERIALS, BIOMECHANICS AND STEM CELLS AT NIH Rosemarie Hunziker Tissue Engineering/Regenerative Medicine, Biomaterials/Biomechanics, and Implantable Medical Devices Program Director National Institute
More informationGrantsmanship at the NIH and the Device Research Landscape. Michael Wolfson, Ph.D. Program Director NIH/NIBIB 11/8/17
Grantsmanship at the NIH and the Device Research Landscape Michael Wolfson, Ph.D. Program Director NIH/NIBIB 11/8/17 The Three Gatekeepers Funder Regulator Payer Impact > Cost & Technical risk Benefit
More informationTECHNOLOGY TRANSFER: THE NIH EXPERIENCE. NIH Mission
TECHNOLOGY TRANSFER: THE NIH EXPERIENCE Jack Spiegel, Ph.D (retired) Senior Advisor for Technology Transfer Operations Office of Technology Transfer National Institutes of Health U.S. Department of Health
More informationBringing Medical Devices for Cancer to the Marketplace: 2014 Overview of the NCI Small Business Programs
Bringing Medical Devices for Cancer to the Marketplace: 2014 Overview of the NCI Small Business Programs A Greg Evans, PhD Team Leader Cancer Imaging/Biology/Control NCI SBIR Development Center Monday
More informationNational Institutes of Health
National Institutes of Health Panel on Federal Research Funding Sources for Computing CRA Conference at Snowbird, UT on June 25-27, 2006 Peter Highnam National Center for Research Resources National Institutes
More informationApril 19, :00-5:00
Funding Landscape Update April 19, 2010 3:00-5:00 Room 923, Allan Rosenfield Building Robyn Gershon, MHS DrPH Associate Dean for Research Resources Mailman School of Public Health Columbia University 2
More informationExceptional Research Opportunities,
Exceptional Research Opportunities, Challenging Times Francis S. Collins, M.D., Ph.D. Director, National Institutes of Health Association of American Medical Colleges Annual Meeting November 7, 2011 Jordan
More informationOutline. How the NIH funds people, projects, and infrastructure in STI modeling
How the NIH funds people, projects, infrastructure in STI modeling Stephen E. Marcus, Ph.D. Program Director Division Biomedical Technology, Bioinformatics Computational Biology Division Training, Workforce
More informationDr. Krishna Balki Balakrishnan Senior Technology Manager, Office of Strategic Alliances National Center for Advancing Translational Sciences, NIH
Dr. Krishna Balki Balakrishnan Senior Technology Manager, Office of Strategic Alliances National Center for Advancing Translational Sciences, NIH Email: Balki@nih.gov Established on December 23, 2011 Part
More informationNINDS/HEAL Biomarker Programs New Biomarker Initiatives at NIH: Neurological Disorders and Pain
NINDS/HEAL Biomarker Programs New Biomarker Initiatives at NIH: Neurological Disorders and Pain OCTOBER 30, 2018 Mary Ann Pelleymounter, PhD Program Director mary.pelleymounter@nih.gov 1 About the Speaker
More informationNATIONAL INSTITUTES OF HEALTH
NATIONAL INSTITUTES OF HEALTH (dollars in millions) 2011 2012 2013 2013 +/- 2012 Institutes National Cancer Institute... 5,050 5,066 5,069 +3 National Heart, Lung and Blood Institute... 3,065 3,075 3,076
More informationChairman Cole, Ranking Member DeLauro and distinguished members of the
Fiscal Year 2019 House Appropriations Committee Subcommittee on Labor, Health and Human Services, Education and Related Agencies Appropriations Testimony Cynthia A. Bens, Senior Vice President, Public
More informationSustaining Institutional Support and Patient Engagement in Clinical Trials: Models and Messages from the NIH Clinical Center
Sustaining Institutional Support and Patient Engagement in Clinical Trials: Models and Messages from the NIH Clinical Center John I. Gallin, MD Director, NIH Clinical Center November 7, 2011 Advancing
More informationNational Institutes of Health
7 National Institutes of Health Erin Heath American Association for the Advancement of Science HIGHLIGHTS The National Institutes of Health (NIH) budget would rise 0.7 percent to $30.4 billion. NIH s fiscal
More informationWeekly NIH Funding Opportunities and Notices NIH Guide for Grants and Contracts January 11, 2019 Table of Contents (TOC) Web Version
Weekly NIH Funding Opportunities and Notices NIH Guide for Grants and Contracts January 11, 2019 Table of Contents (TOC) Web Version Notices Notice of Information: Updates and clarifications of several
More informationORACLE OTTAWA REGION FOR ADVANCED CARDIOVASCULAR RESEARCH EXCELLENCE STRATEGIC DIRECTIONS
ORACLE OTTAWA REGION FOR ADVANCED CARDIOVASCULAR RESEARCH EXCELLENCE STRATEGIC DIRECTIONS 2018-2024 ORACLE 2.0: Leading Globally, from Innovation to Impact P1 P2 NOTE FROM OUR LEADERS NOTE FROM VP RESEARCH,
More informationNIH Update James M. Anderson, M.D., Ph.D. NIH Deputy Director for Program Coordination, Planning, and Strategic Initiatives National Institutes of
NIH Update James M. Anderson, M.D., Ph.D. NIH Deputy Director for Program Coordination, Planning, and Strategic Initiatives National Institutes of Health AIRI Meeting October 2, 2017 Topics Budget Update
More informationThe Curative and Transformative Potential of Novel Therapies for Rare Diseases in the Age of Precision Medicine
The Curative and Transformative Potential of Novel Therapies for Rare Diseases in the Age of Precision Medicine Christopher P. Austin, M.D. Director, NCATS/NIH EveryLife Scientific Workshop September 12,
More informationscarpat@csr.nih.gov 301-435-1109 Biomedical Research in the U.S.A. The Strategic National Importance of NIH Peer Review C.N.R., Roma, March 2007 National Institutes of Health U.S. Department of Health
More informationProgress Through Partnership: Actively Engaging Patient Groups in the Clinical Research Process
Progress Through Partnership: Actively Engaging Patient Groups in the Clinical Research Process Petra Kaufmann, MD, MSc, FAAN Director, Division of Clinical Innovation NCATS/NIH DIA MEETING, WASHINGTON
More informationOffice of Rare Diseases Research Update. Petra Kaufmann, MD, MSc Director, Division of Clinical Innovation Director, Office of Rare Diseases Research
Office of Rare Diseases Research Update Petra Kaufmann, MD, MSc Director, Division of Clinical Innovation Director, Office of Rare Diseases Research > 6,000 rare diseases Many undiagnosed < 500 have any
More informationTOTAL CANCER CARE: CREATING PARTNERSHIPS TO ADDRESS PATIENT NEEDS
TOTAL CANCER CARE: CREATING PARTNERSHIPS TO ADDRESS PATIENT NEEDS William S. Dalton, PhD, MD CEO, M2Gen & Director, Personalized Medicine Institute, Moffitt Cancer Center JULY 15, 2013 MOFFITT CANCER CENTER
More informationChristopher P. Austin, M.D. NCATS Director IQ Symposium December 5, 2012
Christopher P. Austin, M.D. NCATS Director IQ Symposium December 5, 2012 Basic Laboratory Research Clinical Research Improved Public Health Translational Research Population Research Basic Laboratory Research
More informationNeuroscience at NIH. NINDS, NIMH, NIDA, NIA, NICHD, NEI, NIDCD, NIAAA Each has its own disease mission All fund basic science
Neuroscience at NIH NIH s mission is to seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce the
More informationGovernment Bioscience Grant (GBG) Report October 2016 BROAD AGENCY ANNOUNCEMENTS CANCER
www.g2gconsulting.com Government Bioscience Grant (GBG) Report October 2016 Title (Agency) Opp. Number Description Deadline Funding Level Eligibility Link BROAD AGENCY ANNOUNCEMENTS 1. Advanced Research
More informationRare Diseases: Challenges and Opportunities NIH Perspective
Rare Diseases: Challenges and Opportunities NIH Perspective Stephen C. Groft, Pharm.D. Office of Rare Diseases Research (ORDR) National Center for Advancing Translational Science (NCATS) National Institutes
More informationHuman Genomics, Precision Medicine, and Advancing Human Health. The Human Genome. The Origin of Genomics : 1987
Human Genomics, Precision Medicine, and Advancing Human Health Eric Green, M.D., Ph.D. Director, NHGRI The Human Genome Cells Nucleus Chromosome DNA Human Genome: 3 Billion Bases (letters) The Origin of
More informationThe National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) as a source of Non-Dilutive Funding
@FreeMindGrp FreeMind Group The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) as a source of Non-Dilutive Funding FreeMind Group Webinar Jonathan Adalist FreeMind Group, LLC
More informationMAYO CLINIC CENTER FOR BIOMEDICAL DISCOVERY EXCEPTIONAL RESEARCH LEADS TO EXCEPTIONAL PATIENT CARE
MAYO CLINIC CENTER FOR BIOMEDICAL DISCOVERY EXCEPTIONAL RESEARCH LEADS TO EXCEPTIONAL PATIENT CARE THE RESEARCH WE DO TODAY WILL DETERMINE THE TYPE OF MEDICAL AND SURGICAL PRACTICE WE CARRY ON AT THE CLINIC
More informationTestimony of Christopher Newton-Cheh, MD, MPH Volunteer for the American Heart Association
Testimony of Christopher Newton-Cheh, MD, MPH Volunteer for the American Heart Association Before the House Energy and Commerce Subcommittee on Health 21st Century Cures: Examining the Regulation of Laboratory
More informationA bold vision for 2025
Leading the Biomedical Revolution in Precision Health: How Stanford Medicine is Developing the Next Generation of Health Annual Stanford Medicine Population Health Sciences Colloquium October 26, 2015
More informationsocial, and population-based research conducted and supported by the National Institutes of Health (NIH). The
Statement by the Ad Hoc Group for Medical Research on FY 2015 Appropriations for the National Institutes of Health Submitted for the record on March 28, 2014, to the Subcommittee on Labor, Health and Human
More informationPerspectives on 21st Century Air Pollution and Health Research Priorities
Perspectives on 21st Century Air Pollution and Health Research Priorities Srikanth S Nadadur, PhD Program Director Division of Extramural Research and Training National Institute of Environmental Health
More informationLili M. Portilla, MPA Acting Director, Office of Policy, Communications and Strategic Alliances National Center for Advancing Translational Sciences
Lili M. Portilla, MPA Acting Director, Office of Policy, Communications and Strategic Alliances National Center for Advancing Translational Sciences (NCATS), NIH Email: Lili.Portilla@nih.gov Established
More informationThe Role of Research in Supporting Regulation of Biologicals: Building Bridges from Biomedical Discovery to Innovative Products
The Role of Research in Supporting Regulation of Biologicals: Building Bridges from Biomedical Discovery to Innovative Products Jay S. Epstein, M.D. CBER, FDA Biologicals are Complex Products Critical
More informationList of Acronyms. National Institutes of Health Offices, Institutes, and Centers
List of Acronyms National Institutes of Health Offices, Institutes, and Centers Offices: OD Office of the Director Institutes: NCI NEI NHGRI NHLBI NIA NIAAA NIAID NIAMS NIBIB NICHD NIDA NIDCD NIDCR NIDDK
More informationPresidential Commission for the Study of Bioethical Issues 2 nd meeting September
Presidential Commission for the Study of Bioethical Issues 2 nd meeting September 13 14 2010 David B. Weiner, Ph.D. Professor Department of Pathology and Laboratory Medicine University of Pennsylvania
More informationComplex Adaptive Systems Forum: Transformative CAS Initiatives in Biomedicine
Complex Adaptive Systems Forum: Transformative CAS Initiatives in Biomedicine January 18, 2013 Anna D. Barker, Ph.D. Director, Transformative Healthcare Networks C-Director, Complex Adaptive Systems Initiative
More informationNotice of Pre Application Webinar and FAQs for RFAs: RFA OD , RFA OD , RFA OD and RFA OD (NOT OD )
Weekly NIH Funding Opportunities and Notices NIH Guide for Grants and Contracts 06-08-2018 Table of Contents (TOC) All NIH Funding Opportunities and Notices Notices Notice of Intent to Publish a Funding
More informationEducation Critical to Stem Cell Therapy Pipeline
June 2016 Education Critical to Stem Cell Therapy Pipeline Don L. Gibbons Senior Science and Education Communication Officer ABOUT California Institute for Regenerative Medicine (CIRM) CIRM is California
More informationThe National Institutes of Health ICs: mission and funding strategies
The National Institutes of Health ICs: mission and funding strategies Perry Kirkham, Ph.D. Office of the Vice President for Research E-mail: pkirkham@purdue.edu Phone: 63645 NIH Workshop topics and dates
More informationExpedited Reporting. Darlene Kitterman, MBA Director, Investigator Support & Integration Services, OCTRI September 25, 2014
Expedited Reporting Darlene Kitterman, MBA Director, Investigator Support & Integration Services, OCTRI September 25, 2014 Journal of Clinical Research Best Practices Vol. 7, No. 1, January 2011 Can You
More informationFederal Funding for Brain Research. Congressional Support Accelerates Discovery
The American Brain Coalition (ABC) is a non-profit organization that brings together people with disabling brain disorders, the families of those that are affected, and the professionals who research and
More informationUp Close and Personal
Special Report Up Close and With Personal advances in genetics, a new type of medicine has emerged: one that s tailored just for you and your DNA. Could it transform the paradigm of how we treat and prevent
More informationNational Institutes of Health
National Institutes of Health Much of the biomedical research in the United States is supported by the Federal Government, primarily the National Institutes of Health (NIH) 1 NIH Extramural Program Grant
More informationFUNDING OPPORTUNITIES FAIRE: NATIONAL INSTITUTES OF HEALTH
FUNDING OPPORTUNITIES FAIRE: NATIONAL INSTITUTES OF HEALTH ERC Biennial Meeting Theme: Preparing Tomorrow s Leaders October 28, 2014 Grace C.Y. Peng, Ph.D. The NIH Mission NIH is the steward of medical
More informationWikiLeaks Document Release
WikiLeaks Document Release February 2, 2009 Congressional Research Service Report RL33695 The National Institutes of Health (NIH): Organization, Funding, and Congressional Issues Pamela W. Smith, Domestic
More informationCharting Our Future Together: Building a Clinical Trials Enterprise for the 21 st Century
Charting Our Future Together: Building a Clinical Trials Enterprise for the 21 st Century Gary H. Gibbons, M.D. Director National Heart, Lung, and Blood Institute Cardiovascular Clinical Trialists Forum
More informationTHE IMPACT OF THE AFFORDABLE CARE ACT (ACA) ON CANCER RESEARCH, CARE, AND PREVENTION
THE IMPACT OF THE AFFORDABLE CARE ACT (ACA) ON CANCER RESEARCH, CARE, AND PREVENTION William S. Dalton, PhD, MD AACR April 17, 2016 Designing a Federated Model To Support Research & Healthcare Offices
More informationDARTMOUTH COLLEGE OFFICE OF SPONSORED PROJECTS ANNUAL REPORT AND SUPPLEMENT TO THE FINANCIAL REPORT
DARTMOUTH COLLEGE OFFICE OF SPONSORED PROJECTS ANNUAL REPORT AND SUPPLEMENT TO THE FINANCIAL REPORT JUNE 30, 2005 Dartmouth College TELEPHONE (603) 646-3007 Office of Sponsored Projects FAX (603) 646-3670
More informationIRDiRC: Stepping stones towards success Ruxandra Draghia-Akli, MD, PhD, Deputy Director-General
IRDiRC: Stepping stones towards success Ruxandra Draghia-Akli, MD, PhD, Deputy Director-General DG Research and Innovation, European Commission IRDiRC: Stepping stones towards success Ruxandra Draghia-Akli,
More informationCourse Agenda. Day One
Course Agenda BioImmersion: Biotech for the Non-Scientist A three-day, in-depth course that provides the background required for understanding today s fast-paced biotech marketplace. Beginning with an
More informationPersonalized. Health in Canada
Personalized Health in Canada Canadian Institutes of Health Research Personalized Medicine Signature Initiative 2010-2013 0 Dr. Morag Park CIHR Institute of Cancer Research Dr. Paul Lasko CIHR Institute
More informationYour genes. Your roadmap. Health TechNet & Pharmacogenomics (PGx) February 16, Franziska Moeckel AVP, Personalized Health
Your genes. Your roadmap. Health TechNet & Pharmacogenomics (PGx) February 16, 2018 Franziska Moeckel AVP, Personalized Health Your genes. Your roadmap. Overview Inova s Precision Medicine Journey MediMap
More informationExtramural Research Pulmonary Arterial Hypertension. James P. Kiley, M.S., Ph.D. June 20, 2008
Extramural Research Pulmonary Arterial Hypertension James P. Kiley, M.S., Ph.D. June 20, 2008 Outline Overview DLD Programs in PH NHLBI Strategic Plan Future Directions What s new at NIH Current Extramural
More informationImproving Pa-ent Outcomes with Research: The Appliance of Science NIHR UCL Hospitals Biomedical Research Centre
Improving Pa-ent Outcomes with Research: The Appliance of Science NIHR UCL Hospitals Biomedical Research Centre Bryan Williams MD FRCP FESC FAHA Professor of Medicine and BRC Director 29/08/2013 Creating
More informationSMALL BUSINESS INNOVATION RESEARCH (SBIR) SMALL BUSINESS TECHNOLOGY TRANSFER (STTR) GRANT APPLICATIONS
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES PHS 2018-2 OMNIBUS SOLICITATION OF THE NATIONAL INSTITUTES OF HEALTH, CENTERS FOR DISEASE CONTROL AND PREVENTION, AND FOOD AND DRUG ADMINISTRATION FOR SMALL
More informationThe NYSCF Research Institute
Regenerative Medicine Research Update Susan L. Solomon The NYSCF Research Institute New York Pharma Forum February 25, 2016 Regenerative Medicine Research Regenerative medicine uses laboratory grown human
More informationInformation Technology for Genetic and Genomic Based Personalized Medicine. Submitted. April 23, 2008
Information Technology for Genetic and Genomic Based Personalized Medicine Submitted April 23, 2008 By The Harvard Medical School Partners HealthCare Center for Genetics and Genomics in Partnership with
More informationThe 100,000 Genomes Project Genomics Collaboration Event Finnish Residence
The 100,000 Genomes Project Genomics Collaboration Event Finnish Residence Prof Mark Caulfield FMedSci Chief Scientist for Genomics England Barts Heart Centre William Harvey Research Institute Queen Mary
More informationMedical Device Non-Dilutive Funding: Trends & Opportunities
FreeMindGroup FreeMind Group @FreeMindGrp Medical Device Non-Dilutive Funding: Trends & Opportunities B. Stuart Jacobowitz Sr. Director, Business Development December 6, 2017 FreeMind Group FreeMind Group,
More informationTranslational Medicine in the Era of Big Data: Hype or Real?
Translational Medicine in the Era of Big Data: Hype or Real? AAHCI MENA Regional Conference September 27, 2018 AKL FAHED, MD, MPH @aklfahed Disclosures None 2 Outline The Promise of Big Data Genomics Polygenic
More informationThe Science of Families at the National Institutes of Health
Wendy J. Nilsen, Ph.D. National Academies of Science Science of Families Planning Workshop February 23, 2010 The Science of Families at the National Institutes of Health Overview Introduction NIH Overview
More informationNIH-RAID: A ROADMAP Program
NIH-RAID: A ROADMAP Program (Rapid Access to Interventional Development} A Program designed to facilitate the development of new therapeutics The NIH-RAID Pilot Program is intended to reduce some of the
More informationTopic: Genome-Environment Interactions in Inflammatory Skin Disease
Topic: Genome-Environment Interactions in Inflammatory Skin Disease All information regarding future IMI Call topics is indicative and subject to change. Final information about future IMI Calls will be
More informationMedical Topics: Gene Therapy. E. Anne Jackson, FSA MAAA July 30, 2018
Medical Topics: Gene Therapy E. Anne Jackson, FSA MAAA July 30, 2018 Agenda Terminology Crash course in the science Existing FDA-approved gene therapies Underwriting implications 2 Terms related to high
More information6th Form Open Day 15th July 2015
6th Form Open Day 15 th July 2015 DNA is like a computer program but far, far more advanced than any software ever created. Bill Gates Welcome to the Open Day event at the Institute of Genetic Medicine
More informationRegulatory Pathways for Rare Diseases
Regulatory Pathways for Rare Diseases Celia M. Witten, Ph.D., M.D. Deputy Director, FDA Center for Biologics Evaluation and Research Emerging Technologies for Rare Diseases: Clinical and Regulatory Case
More informationWelcome to the Cure RFI Webinar
Welcome to the Cure RFI Webinar May 28, 2014 Thank you for your patience, we will begin shortly. 1 Agenda Welcome & GoTo Tools Lynne Mofenson, NICHD Introductory Remarks Jack Whitescarver, Director, OAR,
More informationNIH Funding for mhealth Research
NIH Funding for mhealth Research Richard Conroy, Ph.D. Director, Division of Applied Science and Technology National Institute of Biomedical Imaging and Bioengineering (NIBIB) National Institutes of Health
More informationDrug Development: Why Does it Cost so Much? Lewis J. Smith, MD Professor of Medicine Director, Center for Clinical Research Associate VP for Research
Drug Development: Why Does it Cost so Much? Lewis J. Smith, MD Professor of Medicine Director, Center for Clinical Research Associate VP for Research Drug Development Process by which new chemical entities
More informationOur second request Our third request
Testimony of Daniel Paul Perez, President & CEO of the FSH Society before the Subcommittee on Labor, Health and Human Services, Education and Related Agencies on the Subject of FY2009 Appropriations for
More informationNon-Dilutive Funding For Clinical Stage R&D
FreeMindGroup FreeMind Group @FreeMindGrp Non-Dilutive Funding For Clinical Stage R&D Meytal Waiss Director, Business Development FreeMind Group The Global Non-Dilutive Funding Leader FreeMind Group, LLC
More informationData Mining for Genomic- Phenomic Correlations
Data Mining for Genomic- Phenomic Correlations Joyce C. Niland, Ph.D. Associate Director & Chair, Information Sciences Rebecca Nelson, Ph.D. Lead, Data Mining Section City of Hope National Medical Center
More informationPLTW Biomedical Science Medical Interventions Course Outline
Follow the fictitious Smith family as you learn about the prevention, diagnosis, and treatment of disease. Play the role of biomedical professionals to analyze case information and diagnose and treat your
More informationOur website:
Biomedical Informatics Summer Internship Program (BMI SIP) The Department of Biomedical Informatics hosts an annual internship program each summer which provides high school, undergraduate, and graduate
More informationNHS ENGLAND BOARD PAPER
NHS ENGLAND BOARD PAPER Paper: PB.30.03.2017/06 Title: Creating a genomic medicine service to lay the foundations to deliver personalised interventions and treatments Lead Director: Professor Sir Bruce
More informationGenomic Medicine for the University of Vermont Health Network
Genomic Medicine for the University of Vermont Health Network The heart and science of medicine. Debra G.B. Leonard, M.D., Ph.D. Chair & Professor, Pathology & Laboratory Medicine Robert Larner, M.D. College
More informationOverview of NIBIB Research Areas and Funding Opportunities. There are 27 Institutes and Centers (ICs) at the NIH NIBIB
Overview of NIBIB Research Areas and Funding Opportunities National Institute of Biomedical Imaging and Bioengineering AAPM August 2, 2016 Steven Krosnick, MD krosnics@mail.nih.gov There are 27 Institutes
More informationI believe that the contributions of animal research to medical science are undeniable.
I want to thank Jill, Kristy and David for organizing this event, the other panelists for participating, David Lazarus for moderating, and to all of you for being here today. I believe that the contributions
More informationOpportunities for industry/smes in EU-funded health research
Opportunities for industry/smes in EU-funded health research Stéphane Hogan, M.Sc, MBA Head of Unit Applied Genomics and Biotechnology for Health DG Research - European Commission 1 Paris, 31 May 2005
More informationWhat is Precision Medicine?
Precision Medicine Precision Medicine describes the delivery of the right treatment to the right person at the right time. It has the power to improve health outcomes by using technology and data to tailor
More informationK Awards: The Career Development Plan
K Awards: The Career Development Plan Stephania A. Cormier, PhD Department of Pediatrics University of Tennessee Health Science Center Le Bonheur Children s Research FoundaCon Types of Mentored Career
More informationPersonalized Human Genome Sequencing
Personalized Human Genome Sequencing Dr. Stefan Platz DABT, Global Head Drug Safety & Metabolism Biomedical research: strengths & limitations of non-animal alternatives 06 December 2016 The Human Genome
More informationNew Frontiers in Personalized Medicine
New Frontiers in Personalized Medicine Oracle Open World Shanghai 2013 Neil de Crescenzo SVP and GM 1 Safe Harbor Statement The following is intended to outline our general product direction. It is intended
More information- OMICS IN PERSONALISED MEDICINE
SUMMARY REPORT - OMICS IN PERSONALISED MEDICINE Workshop to explore the role of -omics in the development of personalised medicine European Commission, DG Research - Brussels, 29-30 April 2010 Page 2 Summary
More informationBiomedical Informatics in BIG DATA Era
Biomedical Informatics in BIG DATA Era Yang C. Fann, Ph.D. Director, Intramural IT and Bioinformatics Program National Institute of Neurological Disorders and Stroke Disclaimer The opinions or assertions
More informationbuilding better science
integrated biology at agilent building better science Integrated Biology: The Quest The complexity of real biology continues to present enormous challenges to researchers seeking answers that can improve
More informationA whole-system approach to delivering personalised medicine and health in Leeds. Mike Messenger
A whole-system approach to delivering personalised medicine and health in Leeds Mike Messenger Capacity and Resource What is the challenge? In 2016, we face the most significant challenges for a generation.
More informationGenetic Basis of Development & Biotechnologies
Genetic Basis of Development & Biotechnologies 1. Steps of embryonic development: cell division, morphogenesis, differentiation Totipotency and pluripotency 2. Plant cloning 3. Animal cloning Reproductive
More informationMolecular Diagnostics
Molecular Diagnostics Part II: Regulations, Markets & Companies By Prof. K. K. Jain MD, FRACS, FFPM Jain PharmaBiotech Basel, Switzerland May 2018 A Jain PharmaBiotech Report A U T H O R ' S B I O G R
More informationClinical studies. BARBORA VLKOVÁ INSTITUTE OF MOLECULAR BIOMEDICINE
Clinical studies BARBORA VLKOVÁ INSTITUTE OF MOLECULAR BIOMEDICINE www.imbm.sk barboravlk@gmail.com Biomedical research 1. Basic research a. In vitro = cell cultures b. In vivo = experimental animals c.
More informationUniversity of Pennsylvania Perelman School of Medicine High Throughput Screening Core
University of Pennsylvania Perelman School of Medicine High Throughput Screening Core Sara Cherry, Ph. D. David C. Schultz, Ph. D. dschultz@mail.med.upenn.edu (215) 573 9641 67 John Morgan Building Mission
More information